Stockholders' Deficiency (Equity) (Tables)

12 Months Ended

Mar. 31, 2019

Schedule of Warrants Outstanding

Warrant issuances, exercises and expirations or cancellations during the years ended March 31, 2019 and 2018, were as follows, resulting in warrants outstanding at the end of those respective periods:

	Broker Warrants			Consultant Warrants			Warrants Issued on Conversion  of Convertible Notes		Private Placement Warrants		Total
As at December 31, 2015		271,742			380,000			-		-		651,742
RTO adjustment*		53,507			74,860			-		-		128,367
After RTO		325,249			454,860			-		-		780,109
Less: Exercised		-			(131,365	)		-		-		(131,365	)
Less: Expired/cancelled		-			(285,279	)		-		-		(285,279	)
Add: Issued		55,433			878,250			-		390,744		1,324,427
As at March 31, 2017		380,682			916,466			-		390,744		1,687,892
Less: Exercised		(222,690	)		(140,000	)		-		-		(362,690	)
Less: Expired/cancelled		(19,935	)		(380,300	)		-		-		(400,235	)
Add: Issued		246,095			273,806			2,734,530		772,978		4,027,409
As at March 31, 2018		384,152			669,972	**		2,734,530		1,163,722		4,952,376
Less: Exercised		(62,838	)		-			-		-		(62,838	)
Less: Expired/cancelled		-			(342,416	)		-		-		(342,416	)
Add: Issued		-			849,601			-		-		849,601
As at March 31, 2019		321,314			1,177,157	**		2,734,530		1,163,722		5,396,723

Exercise Price	$0.78-$3.00	$0.48-$7.59	2.00	3.00
Expiration Date	March 2022 to July 2022	September 2019 to March 2022	March 2020  to November 2022	April 2020 to July 2020

*As explained above, on February 2, 2016 all outstanding warrants at that time had been increased by a factor of 1.197.

**Consultant Warrants do not include 188,806 warrants provided to an officer of the Company as compensation while he was not a member of any Company options plan, otherwise disclosed in Note 9 under stock-based compensation.

Schedule of Fair Value of Option Granted using Valuation Assumptions

The fair value of each option granted is estimated at the time of grant using multi-nominal lattice model using the following assumptions, for each of the respective years ended March 31:

	2019		2018		2017
Exercise price ($)		1.40-2.00		3.69-7.59		2.00 – 2.58
Risk free interest rate (%)		2.27-2.81		1.98-2.39		0.45 - 1.47
Expected term (Years)		2.0-3.0		3.0		1.0 - 3.0
Expected volatility (%)		97.8-141.1		139.75-145.99		101 – 105
Expected dividend yield (%)		0.00		0.00		0.00
Fair value of option ($)		0.588		1.032		0.88
Expected forfeiture (attrition) rate (%)		0.00		0.00		0.00 – 5.00

2015 Equity Incentive Plan [Member]

Schedule of Stock Option Activities

The following table summarizes the stock option activities of the Company:

	Number of  options			Weighted  average exercise price ($)
Granted		3,591,000			0.0001
Exercised		(3,390,503	)		0.0001
Outstanding as of December 31, 2015		200,497			0.0001
Cancelled during 2016		(35,907	)		0.0001
Outstanding as of March 31, 2018		164,590			0.0001
Exercised		(164,590	)		0.0001
Outstanding as of March 31, 2019		-			-

2016 Equity Incentive Plan [Member]

Schedule of Stock Option Activities

	Number of  options		Weighted  average exercise price ($)
Granted		2,709,998		2.2031
Exercised		-		-
Outstanding as of March 31, 2017		2,709,998		2.2031
Granted		1,437,500		5.1676
Exercised		-		-
Outstanding as of March 31, 2018		4,147,498		3.2306
Granted		270,521		1.8096
Exercised		-		-
Outstanding as of March 31, 2019		4,418,019		3.1436